Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Dimensional ETF Trust Dimensional US High Profitability ETF (NY:DUHP)

36.16 +0.09 (+0.25%)
Official Closing Price Updated: 8:00 PM EDT, Jul 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Dimensional ETF Trust Dimensional US High Profitability ETF

GM EV Production To Be Guided By Consumer Demand, Says CFO As Federal Tax Credits Near Expiry
GM CFO said that the company’s recent $4 billion investment in U.S. manufacturing over the next two years gives it the necessary capabilities to produce both internal combustion engine and electric... 
Via Stocktwits
Topics Government
GM’s Mary Barra Highlights Efforts To Mitigate Tariff Impact After Q2 Earnings Take Hit: Retail Sees Levies Impact Consumer Spending
Via Stocktwits
Retail Chatter On BMY Doubles In 24 Hours With Drug Failing To Meet Primary Goal: Here's What Investors Are Thinking
Via Stocktwits
General Motors, LG Energy Solution JV To Upgrade Spring Hill Facility To Scale Low-Cost Battery Cell Making
Via Stocktwits
AbbVie Enters Licensing Agreement For IGI Therapeutics’ Experimental Oncology Drug: Retail Cheers
Under the terms of the agreement, AbbVie will receive exclusive rights to develop, manufacture, and commercialize ISB 2001 across North America, Europe, Japan, and Greater China. 
Via Stocktwits
Topics Product Recall
Gilead, Global Fund Enter Agreement To Supply HIV Prevention Drug To Low & Lower-Middle-Income Countries
Under the agreement, Gilead will supply enough doses of its Lenacapavir drug to reach up to two million people over three years in countries supported by the Global Fund, at no profit to the company. 
Via Stocktwits
Eli Lilly’s Alzheimer’s Drug Gets US FDA Label Update For More Gradual Dosing After Study Shows Reduced Side Effects
The U.S. FDA approved Kisunla, an amyloid-targeting therapy, in July 2024 after a study showed that it significantly slowed cognitive and functional decline in Alzheimer’s patients who were less... 
Via Stocktwits
Johnson & Johnson Submits Supplemental Drug Application To FDA For Schizophrenia Drug Caplyta
J&J gained access to Caplyta by the acquisition of Intra-Cellular Therapies, Inc., which was completed in April. 
Via Stocktwits
Topics Government
GM Stock Rises As US Sales Jump 7% In Q2, Powered By Crossovers
Chevrolet, the company’s biggest brand, witnessed a 5.7% increase in sales in the quarter to 478,322 units, owing to a jump in sales of its Silverado and Equinox vehicles. 
Via Stocktwits
AbbVie To Acquire Capstan Therapeutics For Up To $2.1 Billion To Boost Immunology Portfolio As Humira Sales Drop: Stock Gains In Morning Trade
The acquisition will include Capstan’s lead asset, called CPTX2309, in development for the treatment of B-cell-mediated autoimmune diseases. 
Via Stocktwits
Topics Intellectual Property
Gilead Stock Rises On US Supreme Court Ruling In Favor Of Health Insurers Covering Preventive Care
Jefferies termed the Supreme Court’s ruling an ‘incremental positive’ for Gilead that removes an overhang going into the launch for Yeztugo. 
Via Stocktwits
Trump HHS Pick Robert F. Kennedy Jr.'s Wealth Comes From Family, Law Practice, Oil, Bitcoin
Robert F. Kennedy Jr. owes portions of his wealth to his family name, law, cryptocurrency and oil. Here's a look at his wealth and income. 
Via Benzinga
Topics Government
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.